Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for VCEL

Stock NameVericel Corp Ord
TickerVCEL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92346J1088
LEI54930076YM3PLTDR4B91

Show aggregate VCEL holdings

News associated with VCEL

BTIG Research Downgrades Vericel (NASDAQ:VCEL) to Neutral
Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by BTIG Research from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday, MarketBeat.com reports. VCEL has been the subject of a number of other research reports. Stephens reiterated an “overweight” rating and issued a $67.00 price objective on shares of […] - 2025-09-19 02:50:54
Vericel (NASDAQ:VCEL) Shares Gap Down Following Analyst Downgrade
Vericel Corporation (NASDAQ:VCEL – Get Free Report)’s share price gapped down prior to trading on Wednesday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The stock had previously closed at $33.23, but opened at $31.85. Vericel shares last traded at $31.15, with a volume of 120,872 shares. A number […] - 2025-09-19 02:18:56
Vericel (NASDAQ:VCEL) Reaches New 52-Week Low on Analyst Downgrade
Vericel Corporation (NASDAQ:VCEL – Get Free Report) hit a new 52-week low during mid-day trading on Thursday after BTIG Research downgraded the stock from a buy rating to a neutral rating. The company traded as low as $29.93 and last traded at $30.02, with a volume of 1683483 shares traded. The stock had previously closed […] - 2025-09-18 03:06:42
Vericel Corporation (NASDAQ:VCEL) Given Average Recommendation of “Buy” by Brokerages
Vericel Corporation (NASDAQ:VCEL – Get Free Report) has earned an average recommendation of “Buy” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-08-21 04:24:45
Maryland State Retirement & Pension System Cuts Holdings in Vericel Corporation (NASDAQ:VCEL)
Maryland State Retirement & Pension System trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 13.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 14,387 shares of the biotechnology company’s stock after selling 2,170 shares during the […] - 2025-08-14 05:17:00
Vericel Corporation (NASDAQ:VCEL) Shares Bought by Mutual of America Capital Management LLC
Mutual of America Capital Management LLC grew its stake in Vericel Corporation (NASDAQ:VCEL – Free Report) by 5.9% during the 1st quarter, Holdings Channel reports. The fund owned 158,930 shares of the biotechnology company’s stock after acquiring an additional 8,789 shares during the period. Mutual of America Capital Management LLC’s holdings in Vericel were worth […] - 2025-08-08 04:30:54
Geneva Capital Management LLC Has $60.94 Million Stock Holdings in Vericel Corporation (NASDAQ:VCEL)
Geneva Capital Management LLC grew its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 24.2% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,365,744 shares of the biotechnology company’s stock after purchasing an additional 265,956 shares during the quarter. Vericel […] - 2025-08-04 04:28:58
Envestnet Asset Management Inc. Raises Stock Position in Vericel Corporation (NASDAQ:VCEL)
Envestnet Asset Management Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 15.6% during the first quarter, Holdings Channel reports. The institutional investor owned 204,510 shares of the biotechnology company’s stock after buying an additional 27,526 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Vericel were worth $9,125,000 as of […] - 2025-07-22 06:48:58
Principal Financial Group Inc. Grows Stake in Vericel Corporation (NASDAQ:VCEL)
Principal Financial Group Inc. lifted its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 270,154 shares of the biotechnology company’s stock after purchasing an additional 7,222 shares during the period. Principal Financial Group Inc.’s holdings in Vericel were worth $12,054,000 as of its […] - 2025-07-14 04:52:59
Vericel Corporation (NASDAQ:VCEL) Shares Sold by Amalgamated Bank
Amalgamated Bank trimmed its holdings in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,010 shares of the biotechnology company’s stock after selling 375 shares during the quarter. Amalgamated […] - 2025-07-10 04:40:59
Oregon Public Employees Retirement Fund Cuts Holdings in Vericel Corporation (NASDAQ:VCEL)
Oregon Public Employees Retirement Fund decreased its position in Vericel Corporation (NASDAQ:VCEL – Free Report) by 2.6% in the first quarter, Holdings Channel reports. The institutional investor owned 11,293 shares of the biotechnology company’s stock after selling 300 shares during the period. Oregon Public Employees Retirement Fund’s holdings in Vericel were worth $504,000 as of […] - 2025-07-08 05:24:54
Allspring Global Investments Holdings LLC Reduces Holdings in Vericel Corporation (NASDAQ:VCEL)
Allspring Global Investments Holdings LLC trimmed its position in shares of Vericel Corporation (NASDAQ:VCEL – Free Report) by 4.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 249,441 shares of the biotechnology company’s stock after selling 11,632 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Vericel were worth $10,747,000 […] - 2025-07-04 04:52:25
Vericel Corporation (NASDAQ:VCEL) Given Average Rating of “Buy” by Brokerages
Shares of Vericel Corporation (NASDAQ:VCEL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among brokerages that have updated their coverage on […] - 2025-07-02 05:08:59
Vericel (NASDAQ:VCEL) Receives Overweight Rating from Stephens
Vericel (NASDAQ:VCEL – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued on Monday,Benzinga reports. They presently have a $67.00 price objective on the biotechnology company’s stock. Stephens’ price objective would suggest a potential upside of 61.45% from the company’s previous close. A number of […] - 2025-06-18 03:02:52
GAMMA Investing LLC Has $5.76 Million Position in Vericel Co. (NASDAQ:VCEL)
GAMMA Investing LLC raised its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5,916.5% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 129,175 shares of the biotechnology company’s stock after purchasing an additional 127,028 shares during the quarter. GAMMA Investing LLC’s holdings in Vericel were worth $5,764,000 at the […] - 2025-06-10 04:38:49
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $61.14
Vericel Co. (NASDAQ:VCEL – Get Free Report) has been assigned a consensus rating of “Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have covered the stock in the last year […] - 2025-06-10 03:14:49
Mackenzie Financial Corp Acquires New Stake in Vericel Co. (NASDAQ:VCEL)
Mackenzie Financial Corp bought a new position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 3,924 shares of the biotechnology company’s stock, valued at approximately $215,000. A number of other hedge funds and other institutional investors also recently bought and sold shares of VCEL. […] - 2025-06-06 04:50:53
Vericel Co. (NASDAQ:VCEL) Shares Acquired by Deutsche Bank AG
Deutsche Bank AG grew its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 32.1% in the 4th quarter, HoldingsChannel.com reports. The fund owned 52,999 shares of the biotechnology company’s stock after buying an additional 12,890 shares during the quarter. Deutsche Bank AG’s holdings in Vericel were worth $2,910,000 as of its most recent SEC […] - 2025-05-22 04:45:02
BNP Paribas Financial Markets Reduces Stake in Vericel Co. (NASDAQ:VCEL)
BNP Paribas Financial Markets lowered its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 35.1% in the 4th quarter, Holdings Channel reports. The fund owned 20,699 shares of the biotechnology company’s stock after selling 11,202 shares during the quarter. BNP Paribas Financial Markets’ holdings in Vericel were worth $1,137,000 as of its most recent […] - 2025-05-21 04:30:48
Vericel (NASDAQ:VCEL) Rating Lowered to “Sell” at StockNews.com
Vericel (NASDAQ:VCEL – Get Free Report) was downgraded by equities researchers at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Monday. VCEL has been the topic of a number of other research reports. Stephens reaffirmed an “overweight” rating and set a $65.00 target price on shares of Vericel […] - 2025-05-14 02:14:47
The Manufacturers Life Insurance Company Sells 526 Shares of Vericel Co. (NASDAQ:VCEL)
The Manufacturers Life Insurance Company lowered its position in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 2.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,593 shares of the biotechnology company’s stock after selling 526 shares during […] - 2025-05-13 05:22:54
Price T Rowe Associates Inc. MD Decreases Stake in Vericel Co. (NASDAQ:VCEL)
Price T Rowe Associates Inc. MD lowered its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 2.9% during the fourth quarter, HoldingsChannel reports. The fund owned 29,479 shares of the biotechnology company’s stock after selling 868 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Vericel were worth $1,619,000 as of […] - 2025-05-09 05:47:10
Vericel Co. (NASDAQ:VCEL) Stock Position Boosted by Mariner LLC
Mariner LLC grew its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% during the fourth quarter, Holdings Channel reports. The institutional investor owned 9,209 shares of the biotechnology company’s stock after acquiring an additional 659 shares during the period. Mariner LLC’s holdings in Vericel were worth $506,000 at the end of […] - 2025-05-02 05:09:04
Renaissance Technologies LLC Buys 9,200 Shares of Vericel Co. (NASDAQ:VCEL)
Renaissance Technologies LLC increased its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 11.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 89,500 shares of the biotechnology company’s stock after purchasing an additional 9,200 shares during the period. Renaissance Technologies LLC’s […] - 2025-04-21 04:46:48
Brokerages Set Vericel Co. (NASDAQ:VCEL) Target Price at $60.86
Vericel Co. (NASDAQ:VCEL – Get Free Report) has received a consensus recommendation of “Buy” from the seven brokerages that are currently covering the company, Marketbeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1 year price target among analysts that have covered the stock in the last year is […] - 2025-04-21 02:30:46
Alliancebernstein L.P. Reduces Stake in Vericel Co. (NASDAQ:VCEL)
Alliancebernstein L.P. reduced its stake in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 5.5% in the fourth quarter, Holdings Channel reports. The fund owned 54,730 shares of the biotechnology company’s stock after selling 3,160 shares during the quarter. Alliancebernstein L.P.’s holdings in Vericel were worth $3,005,000 as of its most recent filing with […] - 2025-04-16 04:31:00
Vericel Co. (NASDAQ:VCEL) Shares Sold by Sei Investments Co.
Sei Investments Co. cut its stake in Vericel Co. (NASDAQ:VCEL – Free Report) by 8.2% in the fourth quarter, Holdings Channel reports. The firm owned 59,945 shares of the biotechnology company’s stock after selling 5,320 shares during the period. Sei Investments Co.’s holdings in Vericel were worth $3,291,000 as of its most recent filing with […] - 2025-04-04 06:28:59
Vericel Co. (NASDAQ:VCEL) Stake Reduced by Corebridge Financial Inc.
Corebridge Financial Inc. trimmed its holdings in Vericel Co. (NASDAQ:VCEL – Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,155 shares of the biotechnology company’s stock after selling 1,682 shares during the quarter. Corebridge Financial Inc.’s holdings in Vericel […] - 2025-04-04 05:41:01
Prudential Financial Inc. Sells 4,199 Shares of Vericel Co. (NASDAQ:VCEL)
Prudential Financial Inc. decreased its holdings in shares of Vericel Co. (NASDAQ:VCEL – Free Report) by 7.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,004 shares of the biotechnology company’s stock after selling 4,199 shares during the period. […] - 2025-04-04 04:31:04
Avantax Advisory Services Inc. Purchases 234 Shares of Vericel Co. (NASDAQ:VCEL)
Avantax Advisory Services Inc. boosted its position in Vericel Co. (NASDAQ:VCEL – Free Report) by 1.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,803 shares of the biotechnology company’s stock after acquiring an additional 234 shares during the period. Avantax […] - 2025-03-21 06:47:07

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc VCEL holdings

DateNumber of VCEL Shares HeldBase Market Value of VCEL SharesLocal Market Value of VCEL SharesChange in VCEL Shares HeldChange in VCEL Base ValueCurrent Price per VCEL Share HeldPrevious Price per VCEL Share Held
2025-11-12 (Wednesday)4,285VCEL holding decreased by -14USD 173,285VCEL holding decreased by -3189USD 173,285-14USD -3,189 USD 40.4399 USD 41.05
2025-11-11 (Tuesday)4,299USD 176,474VCEL holding increased by 8856USD 176,4740USD 8,856 USD 41.05 USD 38.99
2025-11-10 (Monday)4,299USD 167,618VCEL holding increased by 215USD 167,6180USD 215 USD 38.99 USD 38.94
2025-11-07 (Friday)4,299USD 167,403VCEL holding increased by 817USD 167,4030USD 817 USD 38.94 USD 38.7499
2025-11-06 (Thursday)4,299VCEL holding decreased by -14USD 166,586VCEL holding increased by 6142USD 166,586-14USD 6,142 USD 38.7499 USD 37.2001
2025-11-05 (Wednesday)4,313VCEL holding decreased by -140USD 160,444VCEL holding decreased by -977USD 160,444-140USD -977 USD 37.2001 USD 36.2499
2025-11-04 (Tuesday)4,453VCEL holding decreased by -28USD 161,421VCEL holding decreased by -3054USD 161,421-28USD -3,054 USD 36.2499 USD 36.705
2025-11-03 (Monday)4,481VCEL holding decreased by -28USD 164,475VCEL holding increased by 6389USD 164,475-28USD 6,389 USD 36.705 USD 35.0601
2025-10-31 (Friday)4,509USD 158,086VCEL holding increased by 2390USD 158,0860USD 2,390 USD 35.0601 USD 34.5301
2025-10-30 (Thursday)4,509USD 155,696VCEL holding decreased by -1578USD 155,6960USD -1,578 USD 34.5301 USD 34.88
2025-10-29 (Wednesday)4,509USD 157,274VCEL holding decreased by -8792USD 157,2740USD -8,792 USD 34.88 USD 36.8299
2025-10-28 (Tuesday)4,509VCEL holding increased by 42USD 166,066VCEL holding increased by 3155USD 166,06642USD 3,155 USD 36.8299 USD 36.4699
2025-10-27 (Monday)4,467USD 162,911VCEL holding increased by 670USD 162,9110USD 670 USD 36.4699 USD 36.3199
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VCEL by Blackrock for IE00B3VWM098

Show aggregate share trades of VCEL

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-12SELL-14 40.440* 44.97 Profit of 630 on sale
2025-11-06SELL-14 38.750* 45.08 Profit of 631 on sale
2025-11-05SELL-140 37.200* 45.12 Profit of 6,317 on sale
2025-11-04SELL-28 36.250* 45.17 Profit of 1,265 on sale
2025-11-03SELL-2837.00034.380 34.642USD -970 45.22 Profit of 296 on sale
2025-10-28BUY4236.83036.860 36.857USD 1,548 45.43
2025-10-24SELL-1436.32036.480 36.464USD -510 45.53 Profit of 127 on sale
2025-10-15BUY8433.59035.050 34.904USD 2,932 45.92
2025-10-02BUY1431.52031.580 31.574USD 442 46.08
2025-09-30BUY2831.47031.980 31.929USD 894 46.25
2025-08-21SELL-1435.44035.790 35.755USD -501 46.69 Profit of 153 on sale
2025-07-31BUY4234.94038.270 37.937USD 1,593 46.83
2025-06-30SELL-2842.55043.570 43.468USD -1,217 47.78 Profit of 121 on sale
2025-06-25SELL-1441.88043.460 43.302USD -606 47.90 Profit of 64 on sale
2025-06-20SELL-2842.02042.750 42.677USD -1,195 48.02 Profit of 150 on sale
2025-05-23BUY1440.92041.310 41.271USD 578 48.96
2025-05-19SELL-1442.54043.250 43.179USD -605 49.20 Profit of 84 on sale
2025-05-15SELL-4241.49042.550 42.444USD -1,783 49.32 Profit of 289 on sale
2025-05-12SELL-1442.65044.270 44.108USD -618 49.50 Profit of 75 on sale
2025-05-09SELL-1441.73043.000 42.873USD -600 49.57 Profit of 94 on sale
2025-04-30SELL-1438.02038.980 38.884USD -544 50.26 Profit of 159 on sale
2025-04-24SELL-2841.09041.150 41.144USD -1,152 50.68 Profit of 267 on sale
2025-04-17SELL-1441.23041.590 41.554USD -582 51.21 Profit of 135 on sale
2025-04-15SELL-4242.02042.370 42.335USD -1,778 51.42 Profit of 382 on sale
2025-04-14SELL-4241.23042.560 42.427USD -1,782 51.53 Profit of 383 on sale
2025-04-09SELL-5644.24044.600 44.564USD -2,496 51.84 Profit of 407 on sale
2025-04-07SELL-9839.90042.580 42.312USD -4,147 52.13 Profit of 962 on sale
2025-04-04SELL-14041.92043.120 43.000USD -6,020 52.25 Profit of 1,295 on sale
2025-03-31BUY1444.62044.700 44.692USD 626 52.55
2025-03-19SELL-2847.43047.550 47.538USD -1,331 53.17 Profit of 158 on sale
2025-03-14SELL-8445.38047.160 46.982USD -3,946 53.45 Profit of 543 on sale
2025-03-13SELL-2845.39046.360 46.263USD -1,295 53.56 Profit of 204 on sale
2025-03-12SELL-47645.81048.510 48.240USD -22,962 53.67 Profit of 2,586 on sale
2025-03-07SELL-2849.56050.360 50.280USD -1,408 53.89 Profit of 101 on sale
2025-03-06SELL-4248.76051.450 51.181USD -2,150 53.97 Profit of 117 on sale
2025-03-03SELL-1449.51052.000 51.751USD -725 54.13 Profit of 33 on sale
2025-02-28SELL-8451.29051.670 51.632USD -4,337 54.17 Profit of 213 on sale
2025-02-26SELL-1452.85053.560 53.489USD -749 54.27 Profit of 11 on sale
2025-02-25SELL-4252.52052.700 52.682USD -2,213 54.30 Profit of 68 on sale
2025-02-18BUY7057.28058.770 58.621USD 4,103 54.19
2025-02-13BUY1456.81057.260 57.215USD 801 54.02
2025-02-12BUY1456.02056.720 56.650USD 793 53.98
2025-02-11BUY4257.51058.470 58.374USD 2,452 53.91
2025-02-06BUY12659.70062.150 61.905USD 7,800 53.58
2025-01-27BUY1459.72059.840 59.828USD 838 52.27
2024-12-30BUY7055.30056.970 56.803USD 3,976 51.78
2024-12-06BUY5656.37057.180 57.099USD 3,198 51.28
2024-12-05BUY1456.52058.560 58.356USD 817 51.10
2024-12-04BUY7058.15059.850 59.680USD 4,178 50.85
2024-11-29BUY7058.14058.500 58.464USD 4,092 49.95
2024-11-27BUY5657.76059.830 59.623USD 3,339 49.27
2024-11-26BUY1458.75058.810 58.804USD 823 48.84
2024-11-21BUY7056.71058.490 58.312USD 4,082 47.37
2024-11-20BUY4257.26057.340 57.332USD 2,408 46.82
2024-11-18BUY16852.89053.780 53.691USD 9,020 45.88
2024-11-12BUY11255.89057.810 57.618USD 6,453 45.21
2024-11-08BUY7054.00054.470 54.423USD 3,810 44.58
2024-11-07BUY21050.03050.760 50.687USD 10,644 44.16
2024-11-06BUY2848.04048.770 48.697USD 1,364 43.84
2024-10-31BUY1444.04045.610 45.453USD 636 43.62
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VCEL

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19224,25038329,50268.1%
2025-09-18210,6424,505422,65649.8%
2025-09-17498,05718848,50058.7%
2025-09-16247,690103604,15841.0%
2025-09-15250,4542,198479,71752.2%
2025-09-12226,7730440,92151.4%
2025-09-11434,58001,188,98636.6%
2025-09-10217,5114507,03642.9%
2025-09-09154,9221,002432,14735.8%
2025-09-08119,0060262,99045.3%
2025-09-05205,6010280,26973.4%
2025-09-04194,4290640,87730.3%
2025-09-03164,172465276,64459.3%
2025-09-02115,4850201,16357.4%
2025-08-2979,4390137,36157.8%
2025-08-2873,1320128,83156.8%
2025-08-27224,056330450,38649.7%
2025-08-26220,3730479,25346.0%
2025-08-25109,6550154,17571.1%
2025-08-22231,2530366,46663.1%
2025-08-21270,34234,260440,51861.4%
2025-08-2061,16280088,72968.9%
2025-08-1955,65235083,44066.7%
2025-08-18223,2810397,65056.2%
2025-08-15152,7820279,45254.7%
2025-08-14121,23143191,22563.4%
2025-08-13155,5390317,59849.0%
2025-08-1299,1126,742139,27271.2%
2025-08-11127,4010226,59556.2%
2025-08-08108,4000153,58970.6%
2025-08-07158,721777213,18674.5%
2025-08-06144,941169222,68965.1%
2025-08-05113,3640155,46072.9%
2025-08-04202,1140265,40676.2%
2025-08-01209,3804,620311,18567.3%
2025-07-31458,9336,157947,63448.4%
2025-07-30201,101400266,95575.3%
2025-07-29156,11634217,86671.7%
2025-07-28126,81033181,31269.9%
2025-07-2566,0150116,39656.7%
2025-07-2498,110197186,19052.7%
2025-07-23190,5560299,77363.6%
2025-07-2294,5612,782216,24043.7%
2025-07-2198,7340243,03040.6%
2025-07-1890,83360240,25637.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.